Catalent (CTLT) Announces Governance Enhancements and New Initiatives to Drive Value streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
US Bancorp DE cut its position in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) by 3.4% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,946 shares of the biopharmaceutical company’s stock after selling 311 shares during the quarter. US Bancorp DE’s […]
PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its price target cut by Royal Bank of Canada from $60.00 to $46.00 in a research note issued to investors on Friday, Benzinga reports. They currently have a sector perform rating on the biopharmaceutical company’s stock. Several other equities research analysts have also recently weighed in on PTCT. […]